Ownership Summary
Drugs Made In America Acquisition Corp. (NASDAQ:DMAAU) appears in 2 institutional 13F filings for the quarter ending March 2026.
- Collectively, these holders controlled 0.1% of Drugs Made In America Acquisition's outstanding shares in March 2026, down from 2.7% in December 2025.
- Their total shares held in DMAAU decreased -88.39% from the prior quarter, while the number of investors in Drugs Made In America Acquisition decreased 87.5% year over year.
- Of these 2 holders, 0 added to their stakes in Drugs Made In America Acquisition, 2 trimmed positions, and 0 made no changes.
- Combined, these investors held 11.52K shares in DMAAU for March 2026, down by 87.72K shares quarter on quarter, and down 3.28Mn shares year over year.
- Clear Street Group Inc. leads ownership in DMAAU with 10.0K shares as of March 31, 2026, equal to 0.05% of outstanding shares.
- Leading sellers of Drugs Made In America Acquisition shares for the quarter ending March 2026 were Clear Street Group Inc. (81.22K), UBS Group AG (6.5K).
- Per Business Quant, the top 2 investors in DMAAU for the quarter ending March 2026 include Clear Street Group Inc. (10.0K), UBS Group AG (1.52K).